*Seizure risk: carbapenems in general have been reported to cause seizure activity in some people.<ref name="accessdata.fda.gov">http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022106s012lbl.pdf</ref> In addition, those who already have a seizure disorder may be at risk for further seizures if they are using valproic acid to control their seizures; doripenem has been found to decrease serum concentrations of valproic acid.<ref name="accessdata.fda.gov"/>

 
*Infection related: use of doripenem can lead to clostridium difficile infection.<ref name="accessdata.fda.gov"/> It has also been noted to increase mortality in people who have ventilator-associated bacterial pneumonia, and is no longer recommended as a treatment for this condition.<ref name="accessdata.fda.gov"/>

 

